Skip to content

Public FDA record

Z-2034-2012: epoc Blood Analysis BGEM Test Cards for use with the epoc(R) Blood Analysis System Product Usage: U

Recall record Z-2034-2012 for Epocal Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2034-2012
Company in FDA record
Epocal Inc
FDA classification date
Jul 19, 2012
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Class II

Reason stated in the source

Customer reported problem while performing incoming QC of newly received lot of test cards. Liquid quality control results were found to be out of range. Further investigation by Epocal determined that a portion of the test card lot (approximately 3000 cards) could potentially report low glucose results.

Source facts

Action
Epocal Inc. sent a Voluntary Product Recall letter dated June 27, 2011 to the affected consignee. The letter identified the affected products, problem and actions to be taken. The letter ask that all products affected by this recall be sent back to Epocal and a replacement may be obtained. For questions call 1-613-738-6912.
Initiated
2011-06-28
Root cause
Device Design
Terminated
2013-12-18
Distribution
US nationwide Distribution in the state of CA.
Recall number
Z-2034-2012
Recall status
Terminated
CDRH record ID
107399
FDA classified
2012-07-19
Recall event number
61147

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗